# Immune Molecular and Inflammatory Cytokines Dysfunction Analysis in Gout Patients With Different Urate Levels

> **NCT02060552** · PHASE4 · COMPLETED · sponsor: **Tongji Hospital** · enrollment: 96 (actual)

## Conditions studied

- Primary Gout

## Interventions

- **DRUG:** Diacerein
- **DRUG:** Colchicine
- **DRUG:** Febuxostat

## Key facts

- **NCT ID:** NCT02060552
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2014-03
- **Final completion:** 2014-04
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2014-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02060552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02060552, "Immune Molecular and Inflammatory Cytokines Dysfunction Analysis in Gout Patients With Different Urate Levels". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02060552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*